Adjuvant Chemotherapy for Non-Small Cell Lung Cancer

被引:0
|
作者
D'Amico, Thomas A. [1 ]
机构
[1] Duke Univ, Med Ctr, Div Thorac Surg, Durham, NC USA
关键词
lung cancer; adjuvant therapy; targeted therapy; outcomes;
D O I
10.1053/j.semtcvs.2005.06.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The survival after complete resection for non-small cell lung cancer (NSCLC) is unsatisfactory. Until recently, the use of adjuvant therapy after resection for early stage disease has not been proven to improve survival. However, the efficacy of adjuvant therapy has been demonstrated in phase III prospective randomized trials. The appropriate use of adjuvant therapy, including biologic therapy, is currently under investigation. © 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:195 / 198
页数:4
相关论文
共 50 条